720762--10/29/2010--NON_INVASIVE_MONITORING_SYSTEMS_INC

related topics

{property, intellectual, protect}

{product, candidate, development}

{stock, price, share}

{interest, director, officer}

{regulation, government, change}

{condition, economic, financial}

{operation, international, foreign}

{cost, regulation, environmental}

We will likely require additional funding, which may not be available to us on acceptable terms, or at all. In addition, we may need to amend our Articles of Incorporation to increase our number of authorized shares of common stock. We terminated the Product and Supply Agreement with Sing Lin and may potentially be obligated to pay amounts under the agreement. We rely on third parties to manufacture and supply our products, and we presently have no agreement with any third party to manufacture and supply our products. The current worldwide economic crisis and concurrent market instability may materially and adversely affect the demand for our products, as well as our ability to obtain credit or secure funds through sales of our stock, which may materially and adversely affect our business, financial condition and ability to fund our operations. Healthcare policy changes, including recently enacted legislation reforming the U.S. healthcare system, may have a material adverse effect on us. The terms of clearances or approvals and ongoing regulation of our products may limit how we manufacture and market our products, which could materially impair our ability to generate anticipated revenues. Our competitors may develop and market products that are more effective, safer or less expensive than our products, negatively impacting our commercial opportunities. If we are unable to obtain and enforce patent protection for our products, our business could be materially harmed. If we are unable to protect the confidentiality of our proprietary information and know-how, the value of our technology and products could be adversely affected. Our commercial success depends significantly on our ability to operate without infringing the patents and other proprietary rights of third parties. If we become involved in patent litigation or other proceedings related to a determination of rights, we could incur substantial costs and expenses, substantial liability for damages or be required to stop our product development and commercialization efforts any of which could materially adversely affect our liquidity, business prospects and results of operations. Failure to obtain regulatory approval outside the United States will prevent us from marketing our products abroad. Non-U.S. governments often impose strict price controls, which may adversely affect our future profitability. Our business is subject to economic, political, regulatory and other risks associated with international operations. Risks Relating to Our Stock. We do not anticipate paying dividends on our common stock in the foreseeable future. Because our common stock is a penny stock, it may be more difficult for investors to sell shares of our common stock, and the market price of our common stock may be adversely affected. Our stock price has been volatile and there may not be an active, liquid trading market for our common stock.

Full 10-K form ▸

720762--10/29/2010--NON_INVASIVE_MONITORING_SYSTEMS_INC_/FL/